<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Littlejohns TJ</submitter><funding>Cancer Research UK</funding><funding>Medical Research Council</funding><funding>National Institute for Health Research (NIHR)</funding><funding>Nicolaus and Margrit Langbehn Foundation</funding><funding>UKRI Future Leaders Fellowship</funding><pagination>697-704</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8974347</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>77(4)</volume><pubmed_abstract>Visual impairment has emerged as a potential modifiable risk factor for dementia. However, there is a lack of large studies with objective measures of vision and with more than 10 years of follow-up. We investigated whether visual impairment is associated with an increased risk of incident dementia in UK Biobank and European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk). In both cohorts, visual acuity was measured using a "logarithm of the minimum angle of resolution" (LogMAR) chart and categorized as no (≤0.30 LogMAR), mild (>0.3 to ≤0.50 LogMAR), and moderate to severe (>0.50 LogMAR) impairment. Dementia was ascertained through linkage to electronic medical records. After restricting to those aged ≥60 years, without prevalent dementia and with eye measures available, the analytic samples consisted of 62 206 UK Biobank and 7 337 EPIC-Norfolk participants, respectively. In UK Biobank and EPIC-Norfolk, respectively, 1 113 and 517 participants developed dementia over 11 and 15 years of follow-up. Using multivariable Cox proportional-hazards models, the hazard ratios for mild and moderate to severe visual impairment were 1.26 (95% confidence interval [CI]: 0.92-1.72) and 2.16 (95% CI: 1.37-3.40), in UK Biobank, and 1.05 (95% CI: 0.72-1.53) and 1.93 (95% CI: 1.05-3.56) in EPIC-Norfolk, compared to no visual impairment. When excluding participants censored within 5 years of follow-up or with prevalent poor or fair self-reported health, the direction of the associations remained similar for moderate impairment but was not statistically significant. Our findings suggest visual impairment might be a promising target for dementia prevention; however, the possibility of reverse causation cannot be excluded.</pubmed_abstract><journal>The journals of gerontology. Series A, Biological sciences and medical sciences</journal><pubmed_title>Visual Impairment and Risk of Dementia in 2 Population-Based Prospective Cohorts: UK Biobank and EPIC-Norfolk.</pubmed_title><pmcid>PMC8974347</pmcid><funding_grant_id>MC_PC_17228</funding_grant_id><funding_grant_id>G1000143</funding_grant_id><funding_grant_id>MR/T040912/1</funding_grant_id><funding_grant_id>NF-SI-0512-10114</funding_grant_id><funding_grant_id>MC-UU_12015/1</funding_grant_id><funding_grant_id>MR/N003284/1</funding_grant_id><funding_grant_id>MC_UU_12015/1</funding_grant_id><funding_grant_id>G0401527</funding_grant_id><funding_grant_id>16896</funding_grant_id><funding_grant_id>14136</funding_grant_id><funding_grant_id>MC_QA137853</funding_grant_id><funding_grant_id>NF-SI-0616-10090</funding_grant_id><funding_grant_id>C864/A14136</funding_grant_id><funding_grant_id>NF-SI-0611-10084</funding_grant_id><pubmed_authors>Luben R</pubmed_authors><pubmed_authors>Brayne C</pubmed_authors><pubmed_authors>Conroy M</pubmed_authors><pubmed_authors>Littlejohns TJ</pubmed_authors><pubmed_authors>Foster PJ</pubmed_authors><pubmed_authors>Hayat S</pubmed_authors><pubmed_authors>Khawaja AP</pubmed_authors><pubmed_authors>Kuzma E</pubmed_authors></additional><is_claimable>false</is_claimable><name>Visual Impairment and Risk of Dementia in 2 Population-Based Prospective Cohorts: UK Biobank and EPIC-Norfolk.</name><description>Visual impairment has emerged as a potential modifiable risk factor for dementia. However, there is a lack of large studies with objective measures of vision and with more than 10 years of follow-up. We investigated whether visual impairment is associated with an increased risk of incident dementia in UK Biobank and European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk). In both cohorts, visual acuity was measured using a "logarithm of the minimum angle of resolution" (LogMAR) chart and categorized as no (≤0.30 LogMAR), mild (>0.3 to ≤0.50 LogMAR), and moderate to severe (>0.50 LogMAR) impairment. Dementia was ascertained through linkage to electronic medical records. After restricting to those aged ≥60 years, without prevalent dementia and with eye measures available, the analytic samples consisted of 62 206 UK Biobank and 7 337 EPIC-Norfolk participants, respectively. In UK Biobank and EPIC-Norfolk, respectively, 1 113 and 517 participants developed dementia over 11 and 15 years of follow-up. Using multivariable Cox proportional-hazards models, the hazard ratios for mild and moderate to severe visual impairment were 1.26 (95% confidence interval [CI]: 0.92-1.72) and 2.16 (95% CI: 1.37-3.40), in UK Biobank, and 1.05 (95% CI: 0.72-1.53) and 1.93 (95% CI: 1.05-3.56) in EPIC-Norfolk, compared to no visual impairment. When excluding participants censored within 5 years of follow-up or with prevalent poor or fair self-reported health, the direction of the associations remained similar for moderate impairment but was not statistically significant. Our findings suggest visual impairment might be a promising target for dementia prevention; however, the possibility of reverse causation cannot be excluded.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Apr</publication><modification>2026-05-09T15:35:08.63Z</modification><creation>2025-04-04T23:04:31.478Z</creation></dates><accession>S-EPMC8974347</accession><cross_references><pubmed>34718565</pubmed><doi>10.1093/gerona/glab325</doi></cross_references></HashMap>